染色体不稳定性降低了对高风险神经母细胞瘤抗GD2免疫治疗结果至关重要的发育表型

Ryan James Rebernick1, Jae Eun Choi2, Calvin Hesse3

  • 1Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; Michigan Center for Translational Pathology, Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.

Cell reports. Medicine
|September 27, 2025
PubMed
概括

高危神经母细胞瘤 (HR-NBL) 治疗结果与特定的瘤遗传特征有关. 染色体11q丢失会降低发育表型,影响患者对抗GD2免疫疗法的反应.